SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-033744
Filing Date
2022-10-18
Accepted
2022-10-18 16:27:32
Documents
1
Period of Report
2022-10-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4069
  Complete submission text file 0000899243-22-033744.txt   5411
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS, INC. 50 NORTHERN AVENUE BOSTON MA 02210
Business Address
SACHS BRUCE I (Reporting) CIK: 0001197036 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 221316232